Prenatal Diagnosis Center, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China.
Beijing Maternal and Child Health Care Hospital, Beijing, China.
Front Endocrinol (Lausanne). 2022 Feb 10;13:805636. doi: 10.3389/fendo.2022.805636. eCollection 2022.
We aimed to assess whether maternal first-trimester low body mass index (BMI) has a protective effect against macrosomia.
This was a cross-sectional study from January 1, 2011, to June 30, 2021, and 84,900 participants were included. The predictive performance of maternal first-trimester and parental pre-pregnancy BMI for macrosomia was assessed using the area under the receiver-operating characteristics curve (AUC). Multivariate logistic regression analyses were performed to evaluate the independent effect of maternal first-trimester low BMI on macrosomia. Interactions were investigated to evaluate the potential variation of the effect of first-trimester low BMI across different groups. Furthermore, interactions were also examined across groups determined by multiple factors jointly: a) gestational diabetes mellitus (GDM)/GDM history status, parity, and maternal age; and b) GDM/GDM history status, fetal sex, and season of delivery.
The proportion of macrosomia was 6.14% (5,215 of 84,900). Maternal first-trimester BMI showed the best discrimination of macrosomia (all Delong tests: < 0.001). The protective effect of maternal first-trimester low BMI against macrosomia remained significant after adjusting for all confounders of this study [adjusted odds ratios (aOR) = 0.37, 95% CI: 0.32-0.43]. Maternal first-trimester low BMI was inversely associated with macrosomia, irrespective of parity, fetal sex, season of delivery, maternal age, and GDM/GDM history status. The protective effect was most pronounced among pregnant women without GDM/GDM history aged 25 to 29 years old, irrespective of parity (multipara: aOR = 0.32, 95% CI: 0.22-0.47; nullipara: aOR = 0.32, 95% CI: 0.24-0.43). In multipara with GDM/GDM history, the protective effect of low BMI was only observed in the 30- to 34-year-old group (aOR = 0.12, 95% CI: 0.02-0.86). For pregnant women without GDM/GDM history, the protective effect of maternal first-trimester low BMI against macrosomia was the weakest in infants born in winter, irrespective of fetal sex (female: aOR = 0.45, 95% CI: 0.29-0.69; male: aOR = 0.39, 95% CI: 0.28-0.55).
Maternal first-trimester low BMI was inversely associated with macrosomia, and the protective effect was most pronounced among 25- to 29-year-old pregnant women without GDM/GDM history and was only found among 30- to 34-year-old multipara with GDM/GDM history. The protective effect of maternal first-trimester low BMI against macrosomia was the weakest in winter among mothers without GDM/GDM history.
评估母亲孕早期低体重指数(BMI)是否对巨大儿有保护作用。
这是一项 2011 年 1 月 1 日至 2021 年 6 月 30 日的横断面研究,共纳入 84900 名参与者。使用受试者工作特征曲线下面积(AUC)评估母体孕早期和父母孕前 BMI 对巨大儿的预测性能。采用多变量逻辑回归分析评估母体孕早期低 BMI 对巨大儿的独立影响。为了评估孕早期低 BMI 对不同组别的影响是否存在差异,进行了交互作用分析。此外,还对以下两个因素联合决定的不同组别进行了交互作用检验:a)妊娠期糖尿病(GDM)/GDM 病史、产次和母亲年龄;b)GDM/GDM 病史、胎儿性别和分娩季节。
巨大儿的比例为 6.14%(5215/84900)。母体孕早期 BMI 对巨大儿的诊断最佳(所有 Delong 检验:<0.001)。在调整本研究所有混杂因素后,母体孕早期低 BMI 对巨大儿的保护作用仍然显著[调整后的优势比(aOR)=0.37,95%CI:0.32-0.43]。母体孕早期低 BMI 与巨大儿呈负相关,与产次、胎儿性别、分娩季节、母亲年龄和 GDM/GDM 病史无关。在没有 GDM/GDM 病史的 25-29 岁孕妇中,这种保护作用最为显著,与产次无关(多产妇:aOR=0.32,95%CI:0.22-0.47;初产妇:aOR=0.32,95%CI:0.24-0.43)。在有 GDM/GDM 病史的多产妇中,低 BMI 的保护作用仅在 30-34 岁组中观察到(aOR=0.12,95%CI:0.02-0.86)。对于没有 GDM/GDM 病史的孕妇,母体孕早期低 BMI 对巨大儿的保护作用在冬季出生的婴儿中最弱,与胎儿性别无关(女性:aOR=0.45,95%CI:0.29-0.69;男性:aOR=0.39,95%CI:0.28-0.55)。
母体孕早期低 BMI 与巨大儿呈负相关,在没有 GDM/GDM 病史的 25-29 岁孕妇中保护作用最显著,在有 GDM/GDM 病史的 30-34 岁多产妇中仅发现保护作用。在没有 GDM/GDM 病史的孕妇中,母体孕早期低 BMI 对巨大儿的保护作用在冬季最弱。